Opportunity Information: Apply for CDC RFA CK11 0010101PPHF11
Apply for CDC RFA CK11 0010101PPHF11
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Public Health Prevention Fund Streamlined Surveillance for Ventilator Associated Pneumonia Reducing Burden and Demonstrating Preventability" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.540 Affordable Care Act Streamlined surveillance for ventilator associated pneumonia Reducing burden and demonstrating prev.
- This funding opportunity was created on Apr 1, 2011 and posted on Apr 1, 2011.
- Applicants must submit their applications by May 3, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,508,825.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The research activities conducted under program announcement CK11 001 Epi centers for the Prevention of Healthcare Associated Infections Antimicrobial Resistance and Adverse Events was established to develop, implement and evaluate the effectiveness of epidemiologically based strategies to improve healthcare quality and patient safety.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Public Health Prevention Fund Streamlined Surveillance for Ventilator Associated Pneumonia Reducing Burden and Demonstrating Preventability" (Funding Opportunity Number CDC RFA CK11-0010101PPHF11) was a Centers for Disease Control and Prevention (CDC) cooperative agreement designed to strengthen and simplify how ventilator-associated pneumonia (VAP) is tracked and evaluated in US healthcare settings. The central public health rationale behind the award is CDC's position that preventing healthcare-associated infections (HAIs) is a "winnable battle," meaning progress is achievable with focused, measurable interventions. VAP is highlighted as both common and deadly among HAIs, making it a high-impact target for prevention efforts. The opportunity is tied to national surveillance infrastructure through CDC's National Healthcare Safety Network (NHSN), which already receives VAP data from facilities using standardized definitions and methods, and the goal is to improve surveillance approaches in ways that reduce reporting burden while still producing credible, comparable data that can support prevention.
From an administrative standpoint, this was a discretionary funding opportunity in the health category, using a cooperative agreement mechanism, which typically implies substantial involvement by CDC in project direction, technical guidance, or coordination rather than a hands-off relationship. The funding was supported through the Affordable Care Act's Prevention Fund stream (CFDA 93.540). Only one award was expected, signaling a single-site or single-lead approach intended to generate a model, toolset, or evidence base that could later be adopted more broadly. The maximum award amount listed was $1,508,825, with no stated minimum (award floor of $0), and there was no cost-sharing or matching requirement, lowering the barrier for eligible applicants to participate.
The eligible applicant category is listed generally as "Others," with clarification indicated in the full announcement, but the eligibility narrative points to an existing CDC-related research framework: the program announcement CK11-001, "Epi Centers for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events." That context suggests the work was meant to align with established epidemiology-centered activities focused on designing, implementing, and evaluating strategies that improve healthcare quality and patient safety. In practical terms, the project focus was less about purely academic research and more about applied public health work: refining surveillance so it is easier to perform, produces actionable information, and helps demonstrate that VAP is preventable through measurable changes in practice.
The timeline shows the announcement was posted and created on April 1, 2011, with an original and current closing date of May 3, 2011, and an archive date of June 2, 2011. This indicates a short application window typical of targeted, time-sensitive federal initiatives. For access issues, CDC directed applicants to its Procurement and Grants Office, Technical Information and Management Section (TIMS), with a phone contact (770-488-2700) for general submission inquiries. The additional information link in the synopsis is noted as inactive, and applicants were instructed to use the full announcement accessed from the synopsis page.
In plain terms, the opportunity was aimed at improving how hospitals and other facilities detect and report VAP through NHSN in a way that is less burdensome for frontline infection prevention teams, while still generating strong enough surveillance data to track progress and show preventability. The broader intent was to produce measurable impact on patient safety by supporting surveillance methods that can guide prevention strategies, document reductions in VAP, and reinforce HAI prevention as an achievable national public health priority.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Public Health Prevention Fund Streamlined Surveillance for Ventilator Associated Pneumonia Reducing Burden and Demonstrating Preventability." The Funding Opportunity Number is CDC RFA CK11-0010101PPHF11.
Which federal agency offered this funding opportunity?
This was offered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is used (grant vs. cooperative agreement)?
This opportunity used a cooperative agreement mechanism. That typically means CDC anticipated substantial involvement in the project through direction, coordination, and/or technical guidance, rather than a fully hands-off relationship.
What is the primary public health purpose of the award?
The purpose was to strengthen and simplify how ventilator-associated pneumonia (VAP) is tracked and evaluated in US healthcare settings, while reducing reporting burden and still producing credible, comparable surveillance data that can support prevention.
Why does CDC focus on ventilator-associated pneumonia (VAP) in this opportunity?
VAP is described as both common and deadly among healthcare-associated infections (HAIs), making it a high-impact target. The CDC rationale frames HAI prevention as a "winnable battle," meaning measurable progress is achievable with focused interventions and credible tracking.
How does this opportunity connect to national surveillance systems?
The work is tied to CDC's National Healthcare Safety Network (NHSN), which already receives VAP data from facilities using standardized definitions and methods. The aim was to improve surveillance approaches within or aligned to NHSN so data remain comparable while reporting becomes less burdensome.
What does "streamlined surveillance" mean in the context of this grant?
Based on the synopsis, it refers to refining VAP surveillance so it is easier for healthcare facilities to perform and report (reducing burden on frontline infection prevention teams) while still producing strong, standardized data that can be used to measure progress and support prevention strategies.
Is this opportunity focused more on research or on applied public health practice?
The emphasis is on applied public health work rather than purely academic research. The stated intent is to refine surveillance in ways that produce actionable information, guide prevention strategies, document reductions, and demonstrate preventability through measurable changes in practice.
What broader CDC priority does this opportunity support?
It supports the national priority of preventing healthcare-associated infections (HAIs), reinforcing CDC's position that HAI prevention is achievable with focused, measurable interventions supported by credible surveillance.
What is the funding source and CFDA number mentioned?
The funding is supported through the Affordable Care Act's Prevention Fund stream, identified as CFDA 93.540.
How many awards were expected?
Only one award was expected, suggesting a single-lead or single-site approach intended to produce a model, toolset, or evidence base that could later be adopted more broadly.
What was the maximum award amount?
The maximum award amount listed was $1,508,825.
Was there a minimum award amount?
No minimum was stated in the synopsis (award floor of $0).
Was cost sharing or matching required?
No cost-sharing or matching requirement was stated.
Who was eligible to apply?
The eligible applicant category is listed as "Others," with clarification indicated in the full announcement. The synopsis also points to alignment with the CDC program announcement CK11-001, "Epi Centers for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events."
What is the relevance of program announcement CK11-001 mentioned in the synopsis?
The eligibility narrative references CK11-001 as an existing CDC-related research and applied epidemiology framework focused on designing, implementing, and evaluating strategies to improve healthcare quality and patient safety in the areas of HAIs, antimicrobial resistance, and adverse events. This suggests the project was expected to align with those established activities and capabilities.
What kinds of outcomes was the project intended to produce?
The synopsis highlights outcomes related to improved surveillance approaches that (1) reduce reporting burden, (2) maintain credible, comparable data, and (3) support prevention by tracking progress, documenting reductions in VAP, and demonstrating preventability through measurable practice changes.
When was the opportunity posted and when did it close?
The announcement was posted and created on April 1, 2011. The original and current closing date was May 3, 2011.
When was the opportunity archived?
The archive date listed was June 2, 2011.
How long was the application window?
Based on the posted date (April 1, 2011) and closing date (May 3, 2011), the application window was relatively short, consistent with targeted, time-sensitive federal initiatives.
Where were applicants instructed to find the full announcement details?
The synopsis notes that the additional information link was inactive and instructs applicants to use the full announcement accessed from the synopsis page.
Who could applicants contact for access or submission issues?
For access issues and general submission inquiries, CDC directed applicants to the Procurement and Grants Office, Technical Information and Management Section (TIMS), at 770-488-2700.
What is the key problem this opportunity tries to solve for healthcare facilities?
The key problem is the burden of VAP reporting and surveillance work in real-world healthcare settings. The opportunity aims to reduce that burden while preserving the credibility and comparability of data needed to track national progress and support prevention efforts.
What is meant by demonstrating "preventability" in the opportunity description?
In this context, "preventability" refers to using credible surveillance data to show that VAP rates can be reduced through measurable changes in practice, supporting the broader CDC view that preventing HAIs is achievable.
Does the synopsis specify the exact surveillance methods or tools to be developed?
No. The synopsis describes the goal of improving and streamlining surveillance and reducing burden while maintaining data quality, but it does not list specific tools, methods, or deliverables in detail.
Does the synopsis define exactly which organizations are included under "Others" for eligibility?
No. It states "Others" and indicates clarification would be in the full announcement, so the synopsis alone does not provide the complete eligibility list.
Is this opportunity still open?
No. The closing date was May 3, 2011, and the opportunity was archived on June 2, 2011.
Browse more opportunities from the same category: Health
Next opportunity: Public Prevention Health Fund Pacific Islands Supplemental Funding for Five Year US Affiliated Pacific Island Collaborative Performance Agreement for Tobacco Control, Diabetes Prevention and Control, and the Behavioral Risk Factor Surveillance System
Previous opportunity: Timor Leste and South Pacific Scholarship Programs
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA CK11 0010101PPHF11
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA CK11 0010101PPHF11) also looked into and applied for these:
| Funding Opportunity |
|---|
| Public Prevention Health Fund Pacific Islands Supplemental Funding for Five Year US Affiliated Pacific Island Collaborative Performance Agreement for Tobacco Control, Diabetes Prevention and Control, and the Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9020302PPHF11 Funding Number: CDC RFA DP09 9020302PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Integrating Multi Dimensional Data to Explore Mechanisms Underlying Mental Disorders (RO1) Apply for RFA MH 12 020 Funding Number: RFA MH 12 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 11 189 Funding Number: PAR 11 189 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Public Prevention Health Fund State Supplemental Funding for Healthy Communities, Tobacco Prevention and Control, Diabetes Prevention and Control, and Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9010201PPHF11 Funding Number: CDC RFA DP09 9010201PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 071 Funding Number: HRSA 11 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| State Implementation Planning Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 081 Funding Number: HRSA 11 081 Agency: Health Resources and Services Administration Category: Health Funding Amount: $75,000 |
| Control of NTD ENVISION Apply for RFA OAA 11 000007 Funding Number: RFA OAA 11 000007 Agency: Agency for International Development Category: Health Funding Amount: $250,000,000 |
| Specialized Alcohol Research Centers (P50) Apply for RFA AA 12 002 Funding Number: RFA AA 12 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,800,000 |
| Comprehensive Alcohol Research Centers (P60) Apply for RFA AA 12 003 Funding Number: RFA AA 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Emergency Countermeasure Dispensing Staffing Plan Apply for CDC RFA TP11 1102 Funding Number: CDC RFA TP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Accelerating the Reduction of Malaria Morbidity and Mortality Program (ARM3) Apply for RFA 680 11 000001 Funding Number: RFA 680 11 000001 Agency: Benin USAID Cotonou Category: Health Funding Amount: $30,000,000 |
| NIMHD Resource Related Minority Health and Health Disparities Research (U24) Apply for RFA MD 11 005 Funding Number: RFA MD 11 005 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| REQUEST FOR COMMENTS South Africa Comprehensive Clinical HIV Related Service, Support and Capacity Development, in line with South African national, provincial and district policies, standards and implementation plans Apply for 674 11 0038 Funding Number: 674 11 0038 Agency: South Africa USAID Pretoria Category: Health Funding Amount: Case Dependent |
| Anchoring Metabolomic Changes to Phenotype (P20) Apply for RFA HL 12 009 Funding Number: RFA HL 12 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basic Research in Calcific Aortic Valve Disease (R01) Apply for RFA HL 12 015 Funding Number: RFA HL 12 015 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pulmonary Vascular Right Ventricular Axis Research Program (R01) Apply for RFA HL 12 021 Funding Number: RFA HL 12 021 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Short Term Institutional Training Grant for Clinician Scientists in Pediatric Respiratory, Sleep and Hematology/Transfusion Medicine (T35) Apply for RFA HL 12 017 Funding Number: RFA HL 12 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pathophysiology of HIV Associated Neurodegeneration in Aging Populations on Long Term Anti Retroviral Therapy (R01) Apply for RFA MH 12 070 Funding Number: RFA MH 12 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pathophysiology of HIV Associated Neurodegeneration in Aging Populations on Long Term Anti Retroviral Therapy (R21) Apply for RFA MH 12 071 Funding Number: RFA MH 12 071 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| 2011 Announcement of Availability of Funds for One Cooperative Agreement to Publish Public Health Reports Apply for SG PHR 11 001 Funding Number: SG PHR 11 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA CK11 0010101PPHF11", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.